Search - tctmd.com

Displaying 1 - 20 of 23

Sort: Relevancy | Date

News Conference News AHA 2024

ZODIAC: Decision-Support Tool Doesn’t Sway Lipid-Lowering Treatments in ACS

Michael O'Riordan

November 21, 2024

News Conference News AHA 2024

US Obesity Epidemic Continues to Skyrocket, With No End in Sight

Michael O'Riordan

November 15, 2024

News Daily News

Liraglutide Helps Shed Weight in Young Children With Obesity

Todd Neale

September 13, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2024

Caitlin E. Cox

September 03, 2024

News Conference News ESC 2024

SENIOR-RITA Offers Rare Insights Into Best Care for Older NSTEMI Patients

Michael O'Riordan

September 02, 2024

News Conference News ESC 2024

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

Michael O'Riordan

September 01, 2024

News Conference News ESC 2024

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

Michael O'Riordan

September 01, 2024

Presentation ESC 2024

Edoxaban-Based Long-Term Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Disease: The EPIC-CAD Randomized Clinical Trial

Presenter: Gi-Byoung Nam

September 01, 2024

News Conference News ESC 2024

Edoxaban Monotherapy Wins for AF and Stable Coronary Disease: EPIC-CAD

Todd Neale

September 01, 2024

News Conference News ESC 2024

Trial Challenges Continuation of Oral Anticoagulants During TAVI

Todd Neale

August 31, 2024

News Conference News ESC 2024

Three Common Biomarkers Closely Tied to Women’s 30-Year Risk of CV Events

Caitlin E. Cox

August 31, 2024

Presentation ESC 2024

BedMed and BedMed-Frail randomized controlled trials

Presenter: Scott Garrison

August 31, 2024

Presentation ESC 2024

QUADRO Phase III Study: Efficacy and Safety of the new Quadruple SPC Perindopril/Indapamide/Amlodipine/Bisoprolol in Patients with Resistant Hypertension

Presenter: Stefano Taddei

August 31, 2024

Presentation ESC 2024

Continuation versus Interruption of Oral Anticoagulation during TAVI

Presenter: Dirk-Jan van Ginkel

August 31, 2024

News Conference News ESC 2024

New BedMed Data Confirm Antihypertensives Can Be Taken Any Time of Day

Yael L. Maxwell

August 31, 2024

News Conference News ESC 2024

Polypills Show Promise in Diverse Hypertensive Patient Groups

L.A. McKeown

August 31, 2024

News Daily News

Scientific Statement Reviews Current Antithrombotic Options in PAD

L.A. McKeown

August 26, 2024

News Daily News

Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA

L.A. McKeown

July 02, 2024

News Daily News

Vutrisiran, an siRNA for ATTR-CM, Meets Primary Endpoint in HELIOS-B

Michael O'Riordan

June 24, 2024

News Daily News

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

L.A. McKeown

May 17, 2024

Advertisement

ZODIAC: Decision-Support Tool Doesn’t Sway Lipid-Lowering Treatments in ACS

US Obesity Epidemic Continues to Skyrocket, With No End in Sight

Liraglutide Helps Shed Weight in Young Children With Obesity

TCTMD’s Top 10 Most Popular Stories for August 2024

SENIOR-RITA Offers Rare Insights Into Best Care for Older NSTEMI Patients

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

Edoxaban-Based Long-Term Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Disease: The EPIC-CAD Randomized Clinical Trial

Edoxaban Monotherapy Wins for AF and Stable Coronary Disease: EPIC-CAD

Trial Challenges Continuation of Oral Anticoagulants During TAVI

Three Common Biomarkers Closely Tied to Women’s 30-Year Risk of CV Events

BedMed and BedMed-Frail randomized controlled trials

QUADRO Phase III Study: Efficacy and Safety of the new Quadruple SPC Perindopril/Indapamide/Amlodipine/Bisoprolol in Patients with Resistant Hypertension

Continuation versus Interruption of Oral Anticoagulation during TAVI

New BedMed Data Confirm Antihypertensives Can Be Taken Any Time of Day

Polypills Show Promise in Diverse Hypertensive Patient Groups

Scientific Statement Reviews Current Antithrombotic Options in PAD

Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA

Vutrisiran, an siRNA for ATTR-CM, Meets Primary Endpoint in HELIOS-B

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content